These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58. Yao YF; Yang Z; Li ZF; Gu J World J Gastroenterol; 2007 Mar; 13(12):1841-6. PubMed ID: 17465478 [TBL] [Abstract][Full Text] [Related]
5. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up. Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193 [TBL] [Abstract][Full Text] [Related]
11. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma? Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871 [TBL] [Abstract][Full Text] [Related]
12. [Tumor diagnosis by immunoscintigraphy with anti-CEA antibodies (Tc-99m MAK BW 431/26)]. Kroiss A; Tuchmann A; Schüller J; Weiss W; Wirth M; Auinger C; Neumayr A Wien Klin Wochenschr; 1989 Sep; 101(18):621-6. PubMed ID: 2815778 [TBL] [Abstract][Full Text] [Related]
13. [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results]. Oliva J; Pimentel G; Peralta R; Borrón M; Ortiz R; Gutiérrez J; Guerra J; Quesada W; Dopico R; Casanova F; Baum RP Rev Esp Med Nucl; 1999; 18(1):5-15. PubMed ID: 10074212 [TBL] [Abstract][Full Text] [Related]
14. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT. Stomper PC; D'Souza DJ; Bakshi SP; Rodriguez-Bigas M; Burke PA; Petrelli NJ Radiology; 1995 Dec; 197(3):688-92. PubMed ID: 7480740 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies. Artiko V; Petrović M; Sobić-Saranović D; Antić A; Koljević-Marković A; Krajnović-Jaksić E; Saranović D; Petrović N; Stojković M; Durutović D; Zuvela M; Radovanović-Bobić A; Galun D; Petrasinović Z; Pavlović S; Krivokapić Z; Obradović V Hepatogastroenterology; 2011; 58(106):347-51. PubMed ID: 21661394 [TBL] [Abstract][Full Text] [Related]
16. CEA-immunoscintigraphy with 99m-technetium correlates with tumour cell differentiation in colorectal cancer. Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH; Dippold WG Eur J Cancer; 1993; 29A(9):1327-9. PubMed ID: 8343279 [TBL] [Abstract][Full Text] [Related]
17. [Successful immunoscintigraphic tumor detection with technetium 99m marked monoclonal anti-CEA antibodies]. Baum RP; Lorenz M; Hertel A; Baew-Christow T; Schwarz A; Hör G Onkologie; 1989 Aug; 12 Suppl 1():26-9. PubMed ID: 2685692 [TBL] [Abstract][Full Text] [Related]
18. [Anti-CEA immunoscintigraphy in postoperative follow-up of tumor patients. Differentiated use of various monoclonal antibody preparations]. Leitha T; Baur M; Steger G; Dudczak R Wien Klin Wochenschr; 1990 Sep; 102(17):503-9. PubMed ID: 2264338 [TBL] [Abstract][Full Text] [Related]
19. [Immunoscintigraphy of a colorectal tumor recurrence using a 99mTc-labeled anti-CEA-antibody]. Rilinger N; Niemann H; Halbfass HJ Rontgenpraxis; 1989 Jul; 42(7):245-7. PubMed ID: 2756446 [No Abstract] [Full Text] [Related]
20. Radioimmunoscintigraphy of colorectal carcinoma with a 99Tcm-labelled anti-CEA monoclonal antibody (BW 431/26). Muxí A; Solá M; Bassa P; Pons F; García A; Moragas M; Lomeña F; Herranz R; Fernández R; Trias M Nucl Med Commun; 1992 Apr; 13(4):261-70. PubMed ID: 1589179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]